Cargando…
COVID-19 convalescent plasma therapy and immunodeficiency
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163564/ https://www.ncbi.nlm.nih.gov/pubmed/34116917 http://dx.doi.org/10.1016/j.tracli.2021.05.007 |
| _version_ | 1783700934638960640 |
|---|---|
| author | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_facet | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_sort | Mungmunpuntipantip, Rujittika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8163564 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81635642021-06-01 COVID-19 convalescent plasma therapy and immunodeficiency Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Transfus Clin Biol Letter to the Editor Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2021-08 2021-05-29 /pmc/articles/PMC8163564/ /pubmed/34116917 http://dx.doi.org/10.1016/j.tracli.2021.05.007 Text en © 2021 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj COVID-19 convalescent plasma therapy and immunodeficiency |
| title | COVID-19 convalescent plasma therapy and immunodeficiency |
| title_full | COVID-19 convalescent plasma therapy and immunodeficiency |
| title_fullStr | COVID-19 convalescent plasma therapy and immunodeficiency |
| title_full_unstemmed | COVID-19 convalescent plasma therapy and immunodeficiency |
| title_short | COVID-19 convalescent plasma therapy and immunodeficiency |
| title_sort | covid-19 convalescent plasma therapy and immunodeficiency |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163564/ https://www.ncbi.nlm.nih.gov/pubmed/34116917 http://dx.doi.org/10.1016/j.tracli.2021.05.007 |
| work_keys_str_mv | AT mungmunpuntipantiprujittika covid19convalescentplasmatherapyandimmunodeficiency AT wiwanitkitviroj covid19convalescentplasmatherapyandimmunodeficiency |